Stryker to Sell its U.S. Spinal Implants Business

The company has been on an M&A hot streak lately but now it's the seller.

I Stock 2153990274
iStock/JHVEPhoto

After a lengthy stretch of acquisitions, medical device company Stryker has become the seller. The company said it has reached an agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, an investment firm specializing in the neuro-musculoskeletal space. The business segment will become part of a newly formed company called VB Spine.

Once the deal is finalized later this year, VB Spine will become a strategic partner to Stryker and get exclusive access to Stryker's surgical robot Mako Spine for use with implants in spine procedures.

Most Read Medical News: 

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Kevin A. Lobo, Chair and Chief Executive Officer, Stryker. "With dedicated resources and a focused strategy, the business will be well positioned to succeed as part of Viscogliosi Brothers.”

“We have long admired Stryker for its comprehensive spine portfolio, incredible talent, and strong culture,” said Marc, John and Anthony Viscogliosi, Co-Founders of Viscogliosi Brothers, LLC. “We see a tremendous opportunity to provide the focus, surgeon-centric innovation, and commercial execution needed to grow the business and further impact patient lives and outcomes.”

The deal includes a binding offer to acquire Stryker’s spinal implants business in France, and the companies said the sale of Stryker’s spinal implants business in other international markets is anticipated.

Stryker's decision to sell off its U.S. spinal implants business comes after the company earlier this month agreed to acquire Inari Medical in a deal valued at $4.9 billion. Last year, Stryker completed its previously announced acquisition of Vertos Medical; wrapped its acquisitions of NICO, a privately held company providing a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures, and care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions.

More in Orthopedic